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Matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry (MS) is an emerging technology for rapid
identification of bacterial and fungal isolates. In comparison to conventional methods, this technology is much less labor intensive and
can provide accurate and reliable results in minutes from a single isolated colony. We compared the cost of performing the bioMérieux
Vitek MALDI-TOF MS with conventional microbiological methods to determine the amount saved by the laboratory by converting to
the new technology. Identification costs for 21,930 isolates collected between April 1, 2013, and March 31, 2014, were directly compared
for MALDI-TOF MS and conventional methodologies. These isolates were composed of commonly isolated organisms, including com-
monly encountered aerobic and facultative bacteria and yeast but excluding anaerobes and filamentous fungi. Mycobacterium tuber-
culosis complex and rapidly growing mycobacteria were also evaluated for a 5-month period during the study. Reagent costs and
a total cost analysis that included technologist time in addition to reagent expenses and maintenance service agreement costs
were analyzed as part of this study. The use of MALDI-TOF MS equated to a net savings of $69,108.61, or 87.8%, in reagent costs
annually compared to traditional methods. When total costs are calculated to include technologist time and maintenance costs,
traditional identification would have cost $142,532.69, versus $68,886.51 with the MALDI-TOF MS method, resulting in a labo-
ratory savings of $73,646.18, or 51.7%, annually by adopting the new technology. The initial cost of the instrument at our usage
level would be offset in about 3 years. MALDI-TOF MS not only represents an innovative technology for the rapid and accurate
identification of bacterial and fungal isolates, it also provides a significant cost savings for the laboratory.
Mass spectrometry (MS) has been traditionally utilized forchemical analysis, although its utility was limited to low-
molecular-weight organic compounds (1). Matrix-assisted laser
desorption ionization–time of flight (MALDI-TOF) MS ex-
panded the field and allowed for the analysis of biological mole-
cules with no theoretical upper limit of mass (2). Previously em-
ployed to determine the mass of peptides and proteins, this
emerging technology has been adapted for rapid identification of
bacterial and fungal isolates in the clinical microbiology labora-
tory. In an increasing number of settings, MALDI-TOF MS has
replaced traditional identification methods, including micros-
copy and determination of phenotypic characteristics, which typ-
ically require multiple steps (3, 4).
The performance of MALDI-TOF MS for the identification of
microorganisms was examined in numerous studies and shown to
be accurate and reliable (5–8). In comparison to conventional
methods, this technology is much less labor intensive and can
provide accurate and reliable results in minutes from a single iso-
lated colony. The only reagents utilized are the target slides that
contain sample spots used for the identification of microorgan-
isms, an organic matrix solution, formic acid for yeast isolates,
pipette tips, and disposable loops or toothpicks for sample appli-
cation. Therefore, reagent rental programs are usually not avail-
able from the two manufacturers of MALDI-TOF MS, so the in-
strument is purchased, which is a large capital cost to the
laboratory. In addition, fairly expensive annual maintenance con-
tracts of $25,000 to $30,000 are needed to ensure limited down-
time of this technically complex equipment. Causes of downtime
are multifaceted and consist of various issues, including time re-
quired for remote access to software for manipulation or tuning,
and hardware maintenance/repair, reducing the time the instru-
ment is available on a given day for identification of isolates. Suf-
ficient protocols need to be in place for times when the MALDI-
TOF MS will be unavailable. Although the initial instrumentation
price is high and maintenance expenses are significant, the cost of
identifying an isolate can be very low. Based on this, use of
MALDI-TOF MS has the potential to improve laboratory effi-
ciency, reduce turnaround times, and lower costs (9).
We compared the cost of performing the bioMérieux Vitek
MALDI-TOF MS (Durham, NC, USA) with that of conventional
microbiological methods to determine the amount saved by the
laboratory after converting to the new technology. This study ex-
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amined the cost savings encountered when reagents and total cost
were calculated.
MATERIALS AND METHODS
Study design. We conducted a 12-month retrospective analysis of poten-
tial cost savings incurred by the Clinical Microbiology and Immunology
Laboratory (CMIL) at the University of North Carolina Hospitals
(UNCH) after implementation of MALDI-TOF MS for routine identifi-
cation of bacteria and yeasts. UNCH is an 803-bed academic medical
center composed of acute care, cancer, children’s, neuroscience, and
women’s hospitals located in Chapel Hill, North Carolina. Identification
costs for 21,930 isolates collected during a 1-year period between April 1,
2013, and March 31, 2014, associated with MALDI-TOF MS and conven-
tional methodologies were directly compared. Specimens consisted of the
most commonly isolated organisms in the clinical microbiology labora-
tory, including Enterobacteriaceae, enterococci, Gram-negative glucose
nonfermenters (GNFs), staphylococci, streptococci, and yeast. A compre-
hensive and structured review of the laboratory information system (SCC
Soft Computer, Clearwater, FL) was conducted to determine the number
of isolates identified during the study period.
Analysis of costs. Three cost calculations were analyzed as part of this
study: reagent cost, a direct cost analysis that included technologist time in
addition to reagent expenses, and a total cost analysis that included re-
agent, technologist, and maintenance costs. Reagent expenditures associ-
ated with traditional microbiological methods and MALDI-TOF MS were
directly calculated for each specimen in the study. A standardized formula
was used to determine total technologist cost: technologist cost  (iden-
tification time per isolate [minutes])  (number of isolates identified) 
(mean base technologist salary [per minute]). This was then added to
reagent costs to derive the direct cost: direct cost  technologist cost 
reagent cost. Lastly, we calculated the total cost with the addition of the
maintenance service agreement contracts to provide a full picture of the
total savings incurred over the life of the instrument: total cost  direct
cost  maintenance cost/isolate.
Since the maintenance contract was a fixed rather than a variable cost,
we determined the maintenance cost based on our actual maintenance
contract amount for fiscal year 2014 and divided that by the total number
of isolates identified. Our maintenance cost for the instrument and soft-
ware for fiscal year 2014 was $29,700, which included the annual service
agreement covering the instrument hardware and Myla software.
Identification time was calculated based on prior experiences with
traditional and MALDI-TOF MS methods. Traditional microbiological
methods utilized by the UNCH CMIL include the Vitek 2 microbial iden-
tification system (bioMérieux, Durham, NC) for identification of Enter-
obacteriaceae. Escherichia coli isolates were an exception, as identification
was based mainly on colony morphology and spot indole (Remel, Lenexa,
KS). Vitek 2, pyrrolidonyl arylamidase (PYR) disks, 6.5% NaCl broth, and
bile esculin agar (Remel, Lenexa, KS) were utilized for identification of
enterococci, while oxidase (Remel), Vitek 2, and molecular sequencing
were used for detection of GNFs. Staphylococci and streptococci were
identified with various agglutination and presumptive (e.g., CAMP, A
disk, P disk) tests. API strips (bioMérieux), CHROMagar Candida media
(Becton, Dickinson and Company, Franklin Lakes, NJ), and rapid assim-
ilation of trehalose (RAT) testing (Remel) for Candida glabrata were used
for yeast identifications (Fig. 1).
For these traditional methods, we provided an average of 6 minutes of
technologist time for a positive identification of all bacterial organisms
except staphylococci. Staphylococcus aureus were traditionally identified
via BactiStaph (Remel, Lenexa, KS), while other Staphylococcus spp. were
detected with a combination of a tube coagulase test and BactiStaph, both
simple agglutination methodologies, and were therefore assigned 3 min-
utes per detection. Yeast isolates were allotted between 3 and 20 minutes
per positive identification, depending on the genus and species of the yeast
isolated. Our laboratory has been able to essentially eliminate the routine
use of biochemical batteries, API strips for yeast identification, RAT test-
ing, and Vitek 2 bacterial identification cards, which significantly cut re-
agent and quality control costs. The UNCH CMIL mean base technologist
salary utilized for this study was $27.00/hour, with an additional 20% for
fringe benefits, totaling $0.54/minute.
The UNCH CMIL laboratory staff went through extensive training
and internal performance monitoring to properly operate the bioMérieux
Vitek MS and enhance workflow. This included exercises on how to apply
the proper amount of colony growth onto the disposable target slides (i.e.,
spotting) to achieve a quality result, troubleshoot identification issues as
they arise, and know when to reanalyze (i.e., refire) a spot. The technolo-
gists were taught to apply one colony per isolate onto a spot on the target
slide, add 1 l of the matrix solution, and allow it to dry. We urge one
sample spot per isolate, no duplicates. An exception would be if various
colony morphologies exist on a plate and the technologist wants to rule
out another organism, then other morphologies would be sampled. For
yeast isolates, 0.5 l of formic acid was applied to the sample and allowed
to dry prior to addition of the organic matrix solution. For workflow, each
technologist evaluated his or her culture, and suspicious colonies were
marked and put aside for testing on MALDI-TOF MS. When a sufficient
batch of cultures is ready to be analyzed, the technologists each spotted
their own isolates, since they were the most familiar with the culture they
just evaluated. The bioMérieux Vitek MALDI-TOF MS utilizes disposable
target slides with three acquisition groups (AGs) per slide. Each acquisi-
tion group has a maximum of 16 spots for identification of isolates, for a
total of 48 sample spots per disposable target slide. Staff were encouraged
to utilize as much of the AG as possible to maximize slide usage. Once an
AG was filled, the slide was inserted into the MALDI-TOF MS for analysis.
Analysis takes only minutes, and the result is usually an organism
identification that is reported out in our laboratory information system.
However, there are a number of reasons that a reportable identification
may not be generated. The first is due to a failure, where no identification
is generated. Spots prepared too thickly or too thinly account for the
largest number of identification failures, underscoring the importance of
proper training. Further reasons for failures include analysis of isolates
that are not included in the current MALDI-TOF MS database and are
ultimately identified by 16S rRNA gene sequencing, isolates that fail to
meet our own internal standards (UNCH CMIL accepts 80% probabil-
ity for valid identification), and isolates that generate identifications that
do not match with colony morphology and are subject to further review.
Additionally, some identifications reveal other morphologies of organ-
FIG 1 Traditional methods required for identification, by organism category.
GNF, Gram-negative glucose nonfermenters.
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isms that have already been identified or were not otherwise reported
independently (e.g., oropharyngeal flora) and as such do not generate a
reportable identification for that particular sample. One drawback of the
instrument is that it cannot distinguish between Escherichia coli and Shi-
gella sp., so testing of these isolates will result in a warning. Isolates that are
non-lactose fermenting and non-beta-hemolytic require further testing
on the Vitek 2 to differentiate.
Costs for MALDI-TOF MS were calculated by tallying the total expen-
ditures required to perform the test. This included the commercial or-
ganic matrix solution for all organisms plus formic acid for yeasts, Vitek
MS target slides, pipette tips for application of the matrix and formic acid
solutions, and toothpicks for applying the colonies to the target slide. To
properly calculate the cost of the disposable target slides, we estimated the
total efficiency of reportable MALDI-TOF MS identifications per slide.
This was estimated at 75%. In other words, three out of every four sample
spots available on the target slide provided an organism identification that
was reportable (Fig. 2). This estimate included unused sample spots and
the inability to acquire reportable identifications. Technologist time was
estimated at 2.5 minutes per isolate for spotting specimens and operating
the instrument, which also included the resampling of failed spots. Addi-
tional technologist and reagent costs associated with instrument reanaly-
sis were not included because they were negligible, as the technologist only
needed to select the sample spot to be reanalyzed and the instrument
automatically retested the isolate. No further technologist time was re-
quired.
With these assumptions, the total reagent cost per isolate was $0.43.
This included $0.10 for the organic matrix solution, $0.01 for the tooth-
pick, $0.06 for the pipette tip, and $0.26 for each sample spot. All cost
estimates were rounded to the nearest cent. The technologist time was
then multiplied by the average technologist salary at UNCH CMIL and
added to the reagent cost to account for direct costs. Calculations were
performed for reagent and direct costs utilizing the aforementioned for-
mulas. Differences in costs between MALDI-TOF MS and conventional
methods are reported in gross and percent savings.
Acid-fast bacilli. As an addendum to the main study, we analyzed
costs over a 5-month period to determine the cost savings of implement-
ing MALDI-TOF MS for the prompt identification of rapidly growing
mycobacteria (RGM) and Mycobacterium tuberculosis complex (MTC).
From May 5 to October 4, 2014, 40 isolates of RGM and MTC were
identified by the CMIL. The process of preparing RGM and MTC isolates
for identification on MALDI-TOF MS is complex and time-consuming,
requiring properly trained laboratory personnel to achieve accurate re-
sults. This procedure involves inactivation of an acid-fast bacillus (AFB)
isolate with 70% ethanol along with mechanical disruption of the organ-
isms with glass beads, centrifugation to concentrate the sample, resuspen-
sion of the pellet with 70% formic acid and acetonitrile, application of the
end product onto the target slide, and covering the specimen with matrix.
These isolates were evaluated using the Saramis database v4.12. This total
process was allotted 23 minutes of technologist time per identification of
RGM and MTC isolates.
In contrast, traditional identification involves molecular sequencing
of the 16S rRNA gene for the determination of most AFB isolates (10). In
our laboratory, where sequencing is done weekly, this typically adds an
extra week or more to the identification. Additionally, differentiation be-
tween two species of RGM, Mycobacterium abscessus and Mycobacterium
chelonae, requires further molecular sequencing, in our case of the hsp65
region, which adds additional cost and time, as this methodology was also
only performed once a week in our laboratory (11). Each molecular se-
quencing method is allotted 25 min of technologist time to complete.
Calculations for RGM and MTC were performed for reagent costs and
total cost utilizing a specialized formula. Reagent costs were directly cal-
culated. For 16S molecular sequencing, reagents equated to $61.39 and
doubled to $122.78 for hsp65 sequencing per test performed. Reagent
costs for MALDI-TOF MS were calculated to be $11.33 with all of the
aforementioned required materials and consumables. Total costs were
then calculated utilizing the direct cost calculation previously mentioned,
where technologist time required for each isolate is added to the direct
reagent cost. Of note, the MALDI-TOF MS total cost was calculated with
testing and identification of only two isolates performed per AG and per
run. This reflected our laboratory workflow, as we batch specimens and
perform MALDI-TOF MS runs for AFB once or twice weekly. Differences
in costs between MALDI-TOF MS and conventional methods are re-
ported in gross and percent savings.
RESULTS
Over the 12-month study, from April 1, 2013, to March 31, 2014,
a total of 21,930 isolates were identified in the UNCH CMIL.
Reagent cost analysis. Traditional identification of the isolates
would have cost $78,689.62 in reagents alone, compared to
$9,581.01 for identification with MALDI-TOF MS. The use of
MALDI-TOF MS equated to a substantial net savings of
FIG 2 Diagram of Vitek disposable target slide utilization and isolate identi-
fication with an optimal and actual scenario.




Reagent costs ($) Cost savings
Traditional MALDI-TOF $ %
Enterobacteriaceae 7,503 27,407.46 3,226.29 24,181.17 88.2
Enterococcus spp. 1,454 8,361.20 625.22 7,735.98 92.5
GNFa 3,489 21,154.03 1,501.56 19,652.47 92.9
Staphylococcus spp. 5,790 8,003.24 2,489.70 5,513.54 68.9
Streptococcus spp. 2,332 10,149.14 1,002.76 9,146.38 90.1
Yeast 1,362 3,614.55 735.48 2,879.07 79.7
Total 21,930 78,689.62 9,581.01 69,108.61 87.8
a Gram-negative glucose nonfermenters.
MALDI-TOF MS Cost Savings
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$69,108.61, or 87.8%, in reagent costs compared to the use of tra-
ditional methods (Table 1). When analyzed by organism type, the
largest savings were realized among Gram-negative GNFs, with a
92.9% reduction in reagent costs with MALDI-TOF MS. Tradi-
tional costs for identifying these organisms mainly involved Vitek
2 and 16S molecular sequencing. This large percentage of savings
was expected, since the use of MALDI-TOF MS for identification
of bacteria and yeasts from culture utilizes a minimal amount of
reagents.
Direct cost analysis. If total costs were calculated to include
technologist time, traditional identification would have cost
$142,532.69, compared to $39,186.51 for identification with
MALDI-TOF MS (Table 2). Therefore, the implementation of MS
for identification of bacteria and yeasts netted a savings of
$103,346.18, or 72.5%. Again, Gram-negative GNFs yielded the
largest savings with MALDI-TOF MS, where 80.9% total cost sav-
ings was observed.
The above calculations represent an estimation of the annual
savings without the maintenance agreement contracts, which
would apply to the first year after purchase of the instrument,
since maintenance is included during the initial year of operation.
To properly calculate the cost savings of each subsequent year,
beginning with year 2, the annual budget of the maintenance con-
tract needs to be added in. With the additional service contracts
added, the laboratory savings fell to $73,646.18, or 51.7% (Table
3). Interestingly, there was a loss of 4.4% in savings for the iden-
tification of Staphylococcus spp. when maintenance agreement
contracts were added to the calculation. There were no other re-
markable differences among the other categories.
Acid-fast bacilli. Through traditional methods utilizing mo-
lecular sequencing, it would have cost the CMIL $5,392.08 to
properly identify the 40 RGM and MTC specimens, or $134.80 per
isolate. The direct cost from MALDI-TOF MS was only $1,403.20,
or $35.08 per isolate, which equates to a 74.0% savings. These
savings were reflected by the reduced cost of reagents required for
MALDI-TOF MS versus molecular sequencing methods, since
technologist times were similar between the two methods (23 and
25 min, respectively). Each isolate that required 16S sequencing
cost the UNCH CMIL $61.39 in reagents, while use of hsp65 dou-
bled that cost. Even with the additional reagents required for per-
forming MALDI-TOF MS, reagent costs accounted for only
$11.33 per isolate, or 89.7% less than molecular sequencing.
Therefore, even during a short period of 5 months, the laboratory
was able to save nearly $4,000, or $100 per identification, by elim-
inating the need for molecular sequencing.
Cost per sample. We also calculated the average cost per sam-
ple identified for the various scenarios described. This simply rep-
resents the mean of the total costs, including reagent, technologist,
and maintenance costs, for all isolates identified during the study
period. Reagent costs for the traditional methods utilized aver-
aged $3.59 per isolate and those for MALDI-TOF MS were only
$0.43 (Fig. 3). Total costs with traditional methods, including re-
agent, technologist time, and maintenance agreement contracts,
were determined to be $6.50 per isolate reported, compared to
$3.14 for with MALDI-TOF MS.
DISCUSSION
The transition from conventional microbiological methods to
MALDI-TOF MS technology resulted in significant cost savings.
The laboratory savings estimate was $73,646.18 (51.7%) in total
costs during the 12-month study (Table 3). This included reagent,
technologist, and maintenance agreement costs. Workflow, which
affects the amount of time a technologist spends on identifying an
isolate, is an important aspect that has direct implications for total




Total cost ($) Cost savings
Traditional MALDI-TOF $ %
Enterobacteriaceae 7,503 51,717.18 13,355.34 38,361.84 74.2
Enterococcus spp. 1,454 13,072.16 2,588.12 10,484.04 80.2
GNFa 3,489 32,458.39 6,211.71 26,246.68 80.9
Staphylococcus spp. 5,790 17,383.04 10,306.20 7,076.84 40.7
Streptococcus spp. 2,332 17,704.82 4,150.96 13,553.86 76.6
Yeast 1,362 10,197.09 2,574.18 7,622.91 74.8
Total 21,930 142,532.69 39,186.51 103,346.18 72.5
a Gram-negative glucose nonfermenters.




Total cost ($) Cost savings
Traditional MALDI-TOF $ %
Enterobacteriaceae 7,503 51,717.18 23,516.72 28,200.46 54.5
Enterococcus spp. 1,454 13,072.16 4,557.29 8,514.87 65.1
GNFa 3,489 32,458.39 10,936.89 21,521.50 66.3
Staphylococcus spp. 5,790 17,383.04 18,147.65 764.61 4.4
Streptococcus spp. 2,332 17,704.82 7,309.21 10,395.61 58.7
Yeast 1,362 10,197.09 4,418.75 5,778.34 56.7
Total 21,930 142,532.69 68,886.51 73,646.18 51.7
a Gram-negative glucose nonfermenters.
Tran et al.
2476 jcm.asm.org August 2015 Volume 53 Number 8Journal of Clinical Microbiology
costs. This includes but is not limited to the number of touches the
technologist performs during the process of isolate determina-
tion. The UNCH CMIL underwent a Lean assessment that was
conducted by bioMérieux as part of the purchase of the MALDI-
TOF MS, which helped the laboratory refine protocols to maxi-
mize time and efforts when identifying specimens with the
MALDI-TOF MS.
Laboratories can maximize resources and minimize costs by
batching runs and waiting for all of the sample spots within an
acquisition group on the target slide to be filled prior to loading
the slides onto the MS; the remaining AGs would be accessible for
additional runs at a later time. This helps boost slide usage effi-
ciency and provides more savings. This philosophy should be
possible for most runs throughout the day without impacting
turnaround time significantly. An optimal scenario assumes max-
imum utilization of reagents and technologist time; i.e., all sample
spots on the disposable slide are utilized, and 100% of the spots
result in a reportable identification (Fig. 2). If this scenario were
true, then the total cost savings would be $80,894.12, or 56.8%,
annually instead of $73,646.18. Realistically, we believe the actual
cost savings are between this optimal scenario and our study cal-
culations, since it is not feasible to expect that every spot will be
utilized on each slide and result in a reportable identification.
Not surprisingly, implementation of MALDI-TOF MS re-
duced reagent costs by 88% compared to the costs of conventional
methods. This is because the only consumables utilized in our
laboratory for MALDI-TOF MS were the disposable target slides,
matrix, formic acid (mainly for yeasts), pipette tips, and tooth-
picks for spotting organisms.
Interestingly, there was only one category where it was less
expensive to perform traditional identification than identification
with MALDI-TOF MS. Identification of Staphylococcus spp. by
MS cost $764.61 more than by the traditional latex agglutination
methods. Although the technologist time and reagent costs were
similar for both methods, addition of the maintenance contract
increased the cost of MALDI-TOF MS identification above that
for conventional identification of Staphylococcus species. How-
ever, traditional methods of identification of Staphylococcus sap-
rophyticus and Staphylococcus lugdunensis required more technol-
ogist time and biochemical tests, which delayed identification of
these organisms for up to 48 h. Additionally, the Vitek MS pro-
vided our laboratory with the ability to identify coagulase-nega-
tive Staphylococcus isolates to the species level, which was not done
previously. This is beneficial for blood and sterile body fluid iso-
lates to help differentiate between true infection and contamina-
tion of blood and sterile body fluid cultures when multiple colo-
nial morphologies were detected (12–14). For us, these benefits far
outweigh the added costs of MALDI-TOF MS. Additionally, some
rapid biochemical tests, such as spot indole for Escherichia coli and
PYR for Streptococcus pyogenes, may be less expensive than MS.
The inclusion and exclusion of certain organisms in this new
methodology is something that each laboratory should consider
and incorporate into implementation protocols, because MALDI-
TOF MS reagent costs, workflow, and maintenance contracts vary
significantly.
Verification studies. Verification studies for implementation
of MALDI-TOF MS began in June 2012, and the laboratory went
live with the first set of organisms in October 2012. For this vali-
dation, we included 731 organisms across 3,411 sample spots.
Through June 2013, the verifications cost an estimated $4,357.78,
and more organisms continue to be verified as we encounter them
in the laboratory.
Acid-fast bacilli. Because of the expense of identifying rapidly
growing mycobacteria and Mycobacterium tuberculosis by molec-
ular means, this group of AFB is likely to be more efficiently iden-
tified by MALDI-TOF MS. Our laboratory cultures AFB through
FIG 3 Mean reagent and total costs (with and without maintenance costs) per identification of isolates by traditional and MALDI-TOF MS methods.
MALDI-TOF MS Cost Savings
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traditional mycobacterial methods utilizing liquid (Bactec MGIT
960 mycobacterial detection system) and solid (Lowenstein-Jen-
sen medium; Becton, Dickinson and Company, Franklin Lakes,
NJ) media. Once positive growth is verified via a Kinyoun stain,
the organism is subcultured to 7H11 medium. After sufficient
growth, the organisms are prepared for identification by MALDI-
TOF MS. The rate of growth determines whether the organism is
an RGM, and colony morphology helps determine whether MTC
is in the differential.
In February 2014, RGM and MTC were added to the menu of
approved organisms for identification on MALDI-TOF MS. These
identifications utilize the research-use-only (RUO) Saramis data-
base v4.12 and incur a higher total cost due to a time-consuming
extraction technique required to process and inactivate the AFB
prior to organism identification by MALDI-TOF MS. These costs
still represent a significant 74% reduction in direct costs after
moving to MALDI-TOF MS from traditional molecular sequenc-
ing methods while reducing the turnaround time.
Capital costs. The main stumbling block with implementing
MALDI-TOF MS in the clinical microbiology setting is the capital
cost of acquiring the instrument. With an approximate $270,000
price tag for the instrument and associated in vitro diagnostics and
RUO software databases, the initial financial hurdle may be too
high for some laboratories to overcome. Moreover, laboratories
must be mindful of the maintenance that is associated with the
MALDI-TOF MS. The UNCH CMIL pays an additional $29,700
annually for instrument and database/software maintenance. Our
laboratory requires MALDI-TOF MS fine-tuning every 3 to 4
weeks and has undergone a full laser and three linear detector
replacements in the 3 years that the instrument has been in use.
The fine-tuning process, which takes several hours, does not in-
terrupt workflow or increase cost in our laboratory, as we batch
specimens and test them once the instrument is ready for opera-
tion again. We estimate that the MALDI-TOF MS was nonfunc-
tional for extended periods (i.e., 18 h) for a total of 4 days during
the study period. During these times, we reverted to traditional
methods of identification. Maintenance is an integral part of
the cost calculation for MALDI-TOF MS and needs to be
strongly considered by every laboratory planning on imple-
menting this technology. It should be noted that maintenance
costs begin in year 2, since the first year is covered by the man-
ufacturer warranty.
Therefore, understanding the cost savings after implementa-
tion of MALDI-TOF MS is important because of its large initial
fiscal investment. With an annual savings estimate of $73,646.18,
coupled with the initial year’s savings of $103,346.18, we antici-
pate that the capital cost of the instrument would be offset in just
3 years. The net savings will only increase as we continue to
validate more organisms by MALDI-TOF MS that will ultimately
require less molecular sequencing and labor-intensive technolo-
gist time for identification.
Limitations. There are several limitations to the study. We
were limited by database inquiries and our financial test cost anal-
yses. The laboratory information system has limited querying ca-
pabilities. While we were able to identify the number of isolates
reported during the study period, we were unable to identify ex-
actly how many sample spots were utilized for identification of the
organisms that were reported. The only way to track this is to
prospectively audit the number of spots that were utilized and
cross-reference that number with the number of isolate reports
that were generated. This was not possible for us due to resource
constraints. We were, however, able to audit all of the spots gen-
erated over a 7-day period and found that 79.6% of the spots
generated a reportable identification. Similarly, a 2-month audit
of our slide usage efficiency revealed that 89.8% of sample spots
were utilized. These surveys showed that our estimate of 75% total
slide efficiency was relatively close to what actually occurs in our
laboratory. However, without prospective monitoring of slide
consumption and efficiency throughout the study period, it is im-
possible to accurately calculate this value.
It should be noted that this was a cost-savings study that
estimated the amount saved by the laboratory after routine
implementation of MALDI-TOF MS for identification of the
more common organisms encountered in the clinical microbi-
ology laboratory. It is not a true cost-effectiveness study that
examines costs compared to a defined clinical or natural out-
come to improve health (15). A cost-effectiveness study would
require evaluation of the turnaround time to results and how it
impacts patient care, which is beyond the scope of this paper.
Further and more in-depth studies, such as that by Tan et al.
(9), are needed to determine the cost-effectiveness of this new
technology.
MALDI-TOF MS not only represents an innovative technology
for the rapid and accurate identification of bacterial and fungal
isolates, it also provides significant cost savings for the laboratory.
Despite the high capital cost of the instrument, the ease of perfor-
mance, the rapid turnaround time to results, and the modest cost
of testing for each sample make this new methodology a paradigm
shift in the field of clinical microbiology.
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